Kumaraguru Raja
Stock Analyst at Brookline Capital
(0.06)
# 4,181
Out of 4,842 analysts
15
Total ratings
16.67%
Success rate
-50.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kumaraguru Raja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PALI Palisade Bio | Maintains: Buy | $16 | $0.69 | +2,227.95% | 2 | May 13, 2025 | |
| QNCX Quince Therapeutics | Initiates: Buy | $9 | $1.04 | +765.38% | 1 | Dec 18, 2024 | |
| SABS SAB Biotherapeutics | Initiates: Buy | $8 | $1.81 | +341.99% | 1 | Jun 7, 2024 | |
| FBRX Forte Biosciences | Initiates: Buy | $100 | $8.25 | +1,112.12% | 2 | May 30, 2024 | |
| OTLK Outlook Therapeutics | Downgrades: Hold | n/a | $1.80 | - | 1 | Aug 30, 2023 | |
| ADIL Adial Pharmaceuticals | Reiterates: Buy | $150 | $0.69 | +21,702.33% | 2 | Jul 11, 2023 | |
| GNTA Genenta Science | Assumes: Buy | $15 | $4.44 | +237.84% | 1 | Jun 29, 2023 | |
| RAIN Rain Enhancement Technologies Holdco | Reinstates: Buy | $21 | $3.71 | +466.04% | 1 | Jan 31, 2023 | |
| MNPR Monopar Therapeutics | Reinstates: Buy | $90 | $31.88 | +182.31% | 1 | Dec 9, 2022 | |
| VERU Veru Inc. | Maintains: Buy | $29 → $31 | $0.51 | +5,987.98% | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,360 | $0.73 | +458,916.39% | 1 | Sep 21, 2021 |
Palisade Bio
May 13, 2025
Maintains: Buy
Price Target: $16
Current: $0.69
Upside: +2,227.95%
Quince Therapeutics
Dec 18, 2024
Initiates: Buy
Price Target: $9
Current: $1.04
Upside: +765.38%
SAB Biotherapeutics
Jun 7, 2024
Initiates: Buy
Price Target: $8
Current: $1.81
Upside: +341.99%
Forte Biosciences
May 30, 2024
Initiates: Buy
Price Target: $100
Current: $8.25
Upside: +1,112.12%
Outlook Therapeutics
Aug 30, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.80
Upside: -
Adial Pharmaceuticals
Jul 11, 2023
Reiterates: Buy
Price Target: $150
Current: $0.69
Upside: +21,702.33%
Genenta Science
Jun 29, 2023
Assumes: Buy
Price Target: $15
Current: $4.44
Upside: +237.84%
Rain Enhancement Technologies Holdco
Jan 31, 2023
Reinstates: Buy
Price Target: $21
Current: $3.71
Upside: +466.04%
Monopar Therapeutics
Dec 9, 2022
Reinstates: Buy
Price Target: $90
Current: $31.88
Upside: +182.31%
Veru Inc.
May 18, 2022
Maintains: Buy
Price Target: $29 → $31
Current: $0.51
Upside: +5,987.98%
Sep 21, 2021
Initiates: Buy
Price Target: $3,360
Current: $0.73
Upside: +458,916.39%